Texas Oncology

Houston, Texas 77070

1 studies enrolling now · 10 studies all time

What they study most

Advanced Breast Cancer, Benign Prostatic Hyperplasia, Gastroenteropancreatic Neuroendocrine Tumors, Metastatic Breast Cancer, Metastatic Pancreatic Cancer, Non-Small Cell Lung Cancer, Overactive Bladder, Pancreatic Adenocarcinoma, Pancreatic Cancer, Prostate Cancer, Prostatectomy, UC (Urothelial Cancer)

Studies at this site

• Sacral Neuromodulation for Male Overactive Bladder (MOAB) — Recruiting now
• Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201) — Completed
• Palbociclib in Real World Practice — Completed
• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• Community-based Neuroendocrine Tumor (NET) Research Study — Completed
• Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naive — Completed
• Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index — Completed
• Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic — Completed
• Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer — Completed